Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NMS Capital Advisors is a private, U.S.-based financial services company focused on investment banking, broker-dealer, and advisory services rather than drug development or healthcare operations. The firm has been described as a globally focused boutique investment bank offering mergers and acquisitions advisory, debt and equity capital raising, strategic advisory, securities brokerage, and wealth or asset management services. It appears to serve clients across multiple sectors and has historically advised some healthcare and life sciences companies, but it is not itself a biotech, pharma, or healthcare product company. For biotech analyst purposes, NMS Capital Advisors is best classified as a financial intermediary and capital markets advisor, not an operating life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NMS Capital Advisors.